INTERMUNE INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2014 | CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals | RE |
| 2014 | Roche : rules out mega deals, open to smaller ones - paper | RE |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | 69 | 02-03-31 | |
Carla Fiankan
LAW | General Counsel | - | 11-07-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 107,969,163 | 107,500,142 ( 99.57 %) | 0 | 99.57 % |
Company contact information
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +4.09% | 43.84B | |
| +46.34% | 41.25B | |
| +9.45% | 41.68B | |
| -10.92% | 27.04B | |
| +9.32% | 25.53B | |
| -24.87% | 18.18B | |
| +29.70% | 12.29B | |
| +1.28% | 12.29B | |
| +7.78% | 11.15B |
- Stock Market
- Equities
- Stock
- Company InterMune Inc
